AN

Ahmed Noor

Active Director Director DIN 07565620
DIN 07565620 First appointment Jul 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value •••• Premium profile

About Ahmed Noor

Data last updated:

Ahmed Noor is a Director at Yashfin Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Yashfin Pharmaceuticals Private Limited reported revenue of ₹18.2 Lakh (FY 2021).

DIN 07565620
Primary Designation Director
Industry Pharma
First Appointment 18 Jul 2016
Oldest Company Age 10 yrs
Largest company Yashfin Pharmaceuticals Private Limited · ₹18.2 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jul 20162016₹18.2 Lakh (FY 2021)Active

Board colleagues of Ahmed Noor

NameDINCompanyDesignation
Haroon Rashid Mansuri07570046Yashfin Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yashfin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ahmed Noor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ahmed Noor

Ahmed Noor currently holds 1 directorship: Yashfin Pharmaceuticals Private Limited (Director, since 18 Jul 2016, revenue ₹18.2 Lakh (FY 2021)).

Ahmed Noor was first appointed on 18 Jul 2016 as Director at Yashfin Pharmaceuticals Private Limited.

The current boards of Ahmed Noor's companies include Haroon Rashid Mansuri (Yashfin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available